Gut health tops 2026 trends
Social posts this week put gut health at the center of 2026 wellness trends, especially for GLP‑1 users, with spotlighted tactics like probiotics, digestive enzymes, and extra fiber to optimize semaglutide results. The conversation is shaping product pitches and sponsorship asks in the wellness creator niche. (x.com)
At Natural Products Expo West (Mar 3–6, 2026), exhibitors spotlighted protein-plus-probiotic and postbiotic formulations explicitly marketed to support GLP‑1 users. (nutritioninsight.com (nutritioninsight.com)) (nutritioninsight.com) The GLP‑1 nutritional support market was valued at about $4.1 billion in 2025 and is projected to grow to roughly $13 billion by 2035 at a ~12.2% CAGR, according to industry analysis for formulators. (iizukashoukai.com (iizukashoukai.com)) (iizukashoukai.com) TD Securities projects the broader GLP‑1 drug market could reach $139 billion by 2030, underscoring downstream demand for companion products. (drugstorenews.com (drugstorenews.com)) (drugstorenews.com) Goldman Sachs analysts estimate as many as 15 million U.S. adults may be on anti‑obesity drugs by 2030, with the industry potentially delivering around $100 billion in annual revenue. (cnbc.com (cnbc.com)) (cnbc.com) Influencer directories published new “Top 60” gut‑health creator lists in early March 2026 as brands seek niche talent for biotics and GLP‑1–adjacent campaigns. (influencers.feedspot.com (influencers.feedspot.com)) (influencers.feedspot.com) Industry commentary calls for creators to be positioned in longer-term, caregiving-style partnerships for GLP‑1 audiences rather than one-off product posts. (advertisingweek.com (advertisingweek.com)) (advertisingweek.com) Major consumer brands have already entered the space: reporting cites Nestlé’s Vital Pursuit and Daily Harvest’s “GLP‑1 support” meal positioning as 2024–2025 precedents for food brands pivoting to GLP‑1–friendly messaging. (vitafoodsinsights.com (vitafoodsinsights.com)) (vitafoodsinsights.com) Ingredient suppliers and formulators also promoted digestive enzymes and branded companion probiotics such as SEBiotic® SlimSEB® as product-level support aimed at GLP‑1 tolerability and gut comfort in 2025–2026 literature. (specialtyenzymes.com (specialtyenzymes.com)) (specialtyenzymes.com) Medical and regulatory voices have flagged rising social misinformation on gut “hacks,” with the Genetic Literacy Project citing AGA warnings and at least one emergency department case after an over‑the‑counter colon‑cleanse from a viral post. (geneticliteracyproject.org (geneticliteracyproject.org)) (geneticliteracyproject.org) The European Medicines Agency launched creator‑facing outreach to promote accurate GLP‑1 messaging under the #HealthNotHype banner, signaling regulator interest in influencer communications. (ema.europa.eu (ema.europa.eu)) (ema.europa.eu)
